Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports. [electronic resource]
Producer: 20160216Description: 1223-32 p. digitalISSN:- 1744-8301
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- ErbB Receptors -- antagonists & inhibitors
- Female
- Histone Deacetylase Inhibitors -- therapeutic use
- Humans
- Lapatinib
- Molecular Targeted Therapy
- Neoplasms, Glandular and Epithelial -- drug therapy
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Pleural Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-kit -- antagonists & inhibitors
- Quinazolines -- administration & dosage
- Receptor, IGF Type 1
- Receptors, Somatomedin -- antagonists & inhibitors
- Sorafenib
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Thymus Neoplasms -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.